Kataoka S, Kobayashi H, Chiba K, Nakamura M, Shinada S, Morita S, Lin M, Shibata Y
Saiseikai Sanjo Hospital, 6-18 Inohata, Sanjo City, Niigata 955-8511, Japan.
Transfus Med. 2004 Dec;14(6):419-23. doi: 10.1111/j.1365-3148.2004.00537.x.
We report the second case of neonatal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-3b (Bak(b)) antibody. The infant was severely affected with intracranial haemorrhage. Most importantly, we were able to detect this antibody only by using fresh, unfixed platelets as antigen. This antibody was detectable neither by conventional mixed passive haemagglutination, platelet immunofluorescence test using fixed platelets, nor by monoclonal antigen immobilization of platelet antigen assay using solubilized platelets. We assume that this antibody reacts only with fresh platelets and that the antigen is a labile component of HPA-3b (Bak(b)).
我们报告了第二例因抗人血小板抗原(HPA)-3b(Bak(b))抗体导致的新生儿同种免疫性血小板减少症。该婴儿因颅内出血而受到严重影响。最重要的是,我们仅通过使用新鲜、未固定的血小板作为抗原才检测到这种抗体。无论是传统的混合被动血凝试验、使用固定血小板的血小板免疫荧光试验,还是使用溶解血小板的血小板抗原单克隆抗原固定试验,均无法检测到这种抗体。我们推测这种抗体仅与新鲜血小板发生反应,且抗原是HPA-3b(Bak(b))的一种不稳定成分。